A photo of Meilan Rutter.

Meilan M. Rutter, MD


  • Medical Director, Differences of Sex Development (DSD) Center
  • Assistant Director, Pediatric Endocrinology Fellowship Training Program
  • Associate Professor, UC Department of Pediatrics

About

Biography

Meilan Rutter is board-certified in pediatric endocrinology, and has been on the faculty of Cincinnati Children’s Hospital Medical Center and the University of Cincinnati since 2008. She completed her training in the United Kingdom, New Zealand and Cincinnati. She serves as the medical director of the Cincinnati Children’s Differences of Sex Development (DSD) Center and the assistant director of the pediatric endocrinology fellowship training program.

Dr. Rutter cares for children and adolescents with a wide spectrum of endocrine conditions, including growth, puberty, thyroid and adrenal disorders. She collaborates with interdisciplinary specialists to deliver the endocrine aspects of comprehensive and integrated care for patients with complex conditions. She leads the Cincinnati Children’s DSD Center, which provides interdisciplinary care for people born with conditions affecting reproductive development. The DSD Center is a member of the DSD-Translational Research Network, a national network that strives to optimize and standardize clinical practices and advance scientific knowledge in this field. Dr. Rutter also serves as the primary endocrine consultant for the Cincinnati Comprehensive Neuromuscular Center. In conjunction with the neuromuscular team, she has helped pioneer global awareness of the importance of endocrine issues in patients affected by Duchenne Muscular Dystrophy.

Additional Languages

French, Mandarin

Locations (2)

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Emergency Planning as Part of Healthcare Transition Preparation for Patients with Duchenne Muscular Dystrophy. Chouteau, WA; Burrows, C; Wittekind, SG; Rutter, MM; Bange, JE; Sabla, GE; Rybalsky, I; Tian, C. Journal of Pediatric Nursing. 2021; 61:298-304.

Age-related changes in appendicular lean mass in males with Duchenne muscular dystrophy: A retrospective review. Summer, SS; Wong, BL; Rutter, MM; Horn, PS; Tian, C; Rybalsky, I; Shellenbarger, KC; Kalkwarf, HJ. Muscle and Nerve. 2021; 63:231-238.

Safety and efficacy of teriparatide treatment for severe osteoporosis in patients with Duchenne muscular dystrophy. Nasomyont, N; Keefe, C; Tian, C; Hornung, L; Khoury, J; Tilden, JC; Hochwalt, P; Jackson, E; Rybalsky, I; Wong, BL; et al. Osteoporosis International. 2020; 31:2449-2459.

XY Gonadal Dysgenesis in a Phenotypic Female Identified by Direct-to-Consumer Genetic Testing. Kim, A; Abell, K; Johnson, J; Cizek, S; Breech, L; Ernst, MM; Hopkin, RJ; Kennedy, K; Stanek, J; Strine, AC; et al. Pediatrics. 2020; 146.

Poorly differentiated thyroid carcinoma of childhood and adolescence: a distinct entity characterized by DICER1 mutations. Chernock, RD; Rivera, B; Borrelli, N; Hill, DA; Fahiminiya, S; Shah, T; Chong, A; Aqil, B; Mehrad, M; Giordano, TJ; et al. Modern Pathology. 2020; 33:1264-1274.

Oral bisphosphonate treatment in patients with Duchenne muscular dystrophy on long term glucocorticoid therapy. Tian, C; Wong, BL; Hornung, L; Khoury, JC; Rybalsky, I; Shellenbarger, KC; Rutter, MM. Neuromuscular Disorders. 2020; 30:599-610.

Newborn Screening Protocols and Positive Predictive Value for Congenital Adrenal Hyperplasia Vary across the United States. Speiser, PW; Chawla, R; Chen, M; Diaz-Thomas, A; Finlayson, C; Rutter, MM; Sandberg, DE; Shimy, K; Talib, R; Cerise, J; et al. International Journal of Neonatal Screening. 2020; 6.

Recombinant human insulin-like growth factor-1 therapy for 6 months improves growth but not motor function in boys with Duchenne muscular dystrophy. Rutter, MM; Wong, BL; Collins, JJ; Sawnani, H; Taylor, MD; Horn, PS; Backeljauw, PF. Muscle and Nerve. 2020; 61:623-631.

Loss-of-Function Variants in PPP1R12A: From Isolated Sex Reversal to Holoprosencephaly Spectrum and Urogenital Malformations. Hughes, JJ; Alkhunaizi, E; Kruszka, P; Pyle, LC; Grange, DK; Berger, SI; Payne, KK; Masser-Frye, D; Hu, T; Christie, MR; et al. American Journal of Human Genetics. 2020; 106:121-128.

Differentiated Thyroid Cancer in the Pediatric/Adolescent Population: Evolution of Treatment. Remiker, AS; Chuang, J; Corathers, S; Rutter, MM; Rutter, MJ; Myer, CM; Gelfand, MJ; Trout, AT; Geller, JI. Journal of Pediatric Hematology/Oncology. 2019; 41:532-536.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey